Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2003
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086319A2 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003WO2003002064A3 Fused pyrimidine dhfr inhibitors as antibacterials
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199688 Macrocyclic module compositions
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent
10/23/2003US20030199544 Substituted piperidines, useful for treating cancer
10/23/2003US20030199543 Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase
10/23/2003US20030199542 Farnesyltransferase inhibitors
10/23/2003US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app)
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199536 An amide derivative used as cannabinoid antagonist for the treatment of obesity, schizophrenia, memory dysfunction and marijuana abuse
10/23/2003US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199511 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199393 N- ([1,2,4,] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2480879A1 Tyrosine kinase inhibitors
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353931A1 Transition metal complexes with proton sponges as ligands
10/22/2003EP1353921A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
10/22/2003EP1353920A1 Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353750A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
10/22/2003EP1219621B1 Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1084122B1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/22/2003EP0892802B1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003CN1451065A Chlorohydrin and cationic compounds having high affinity for pulp paper
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome
10/22/2003CN1450896A Use of indole derivatives for intracular pressure for reducing
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635653 Spiropyrazole compounds
10/21/2003US6635652 Senile dementia and Alzheimer's disease
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/21/2003US6635632 Alzheimer's disease
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195375 Process for preparing zolpidem
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195217 More potent than morphine, side effect reduction, free of withdrawal symptoms
10/16/2003US20030195216 Octahydro-2H-pyrido[1,2-a] pyrazine compounds
10/16/2003US20030195209 An stimulant induces the biosynthesis of cytokines, useful for the treatment viral diseases and tumor; viricides, antitumor agents
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195197 Non-nucleoside reverse transcriptase inhibitors
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195189 For therapy of hyperproliferative diseases
10/16/2003US20030195118 And aryl sulfide derivatives
10/16/2003US20030193043 Red organic electroluminescent materials
10/16/2003US20030192226 Animal decoy
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351684A2 Compounds and methods for promoting smoking cessation
10/15/2003EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
10/15/2003EP1140929B1 1h-imidazo 4,5-d]pyridazin-7-ones, 3h-imidazo 4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands
10/15/2003EP0977757B1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003CN1449384A Novel ester or amide derivatives
10/15/2003CN1124264C Process for preparing quinolone- and naphthyridonecarboxylic acids and esters thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632919 Bind Watson-Crick base pairs in a double helix; specific for thymidine
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/14/2003US6632822 Compounds and therapeutic methods
10/14/2003US6632819 Antiviral azaindole derivatives
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/09/2003WO2003082871A1 Imidazo fused compounds
1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 646